Adarshcure Medicity Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 16.87%
- Profit Growth -28.26%
- Ebitda 5.51%
- Net Worth 17.31%
- Total Assets 15.39%
About Adarshcure Medicity
Adarshcure Medicity Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 December 2010 and has a history of 14 years and two months. Its registered office is in Varanasi, Uttar Pradesh, India.
The Corporate was formerly known as Anurag Medical And Research Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suman Singh, Devi Singh, and Stuti serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93030UP2010PTC042920
- Company No.
042920
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Adarshcure Medicity?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Singh  | Director | 22-Dec-2010 | Current |
| Devi Singh | Director | 22-Dec-2010 | Current |
| Stuti | Director | 07-Nov-2018 | Current |
Financial Performance of Adarshcure Medicity.
Adarshcure Medicity Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.87% increase. The company also saw a substantial fall in profitability, with a 28.26% decrease in profit. The company's net worth Soared by an impressive increase of 17.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adarshcure Medicity?
In 2020, Adarshcure Medicity had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adarshcure Medicity?
Unlock and access historical data on people associated with Adarshcure Medicity, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adarshcure Medicity, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adarshcure Medicity's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.